6:21 PM
 | 
Jun 11, 2007
 |  BC Extra  |  Company News

EC approves Tracleer to reduce digital ulcers

The European Commission granted marketing approval for Tracleer bosentan from Actelion (SWX:ATLN) to...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >